Published in J Psychiatr Res on April 02, 2012
Computational psychiatry as a bridge from neuroscience to clinical applications. Nat Neurosci (2016) 1.04
Stable remission and recovery after acute-phase cognitive therapy for recurrent major depressive disorder. J Consult Clin Psychol (2014) 0.85
Predicting relapse after antidepressant withdrawal - a systematic review. Psychol Med (2016) 0.75
Ten ways to improve the treatment of depression and anxiety in adults. Ment Health Fam Med (2013) 0.75
A rating scale for depression. J Neurol Neurosurg Psychiatry (1960) 90.89
An inventory for measuring depression. Arch Gen Psychiatry (1961) 84.61
Research diagnostic criteria: rationale and reliability. Arch Gen Psychiatry (1978) 15.32
Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrence. Arch Gen Psychiatry (1991) 8.37
Report by the ACNP Task Force on response and remission in major depressive disorder. Neuropsychopharmacology (2006) 3.80
Duration of major depressive episodes in the general population: results from The Netherlands Mental Health Survey and Incidence Study (NEMESIS). Br J Psychiatry (2002) 3.28
Multiple recurrences of major depressive disorder. Am J Psychiatry (2000) 3.23
Major depressive disorder: a prospective study of residual subthreshold depressive symptoms as predictor of rapid relapse. J Affect Disord (1998) 2.75
Recovery from major depression. A 10-year prospective follow-up across multiple episodes. Arch Gen Psychiatry (1997) 2.36
Does incomplete recovery from first lifetime major depressive episode herald a chronic course of illness? Am J Psychiatry (2000) 1.89
Prophylactic effect of citalopram in unipolar, recurrent depression: placebo-controlled study of maintenance therapy. Br J Psychiatry (2001) 1.66
The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) Study: Outcomes from the 2-year and combined maintenance phases. J Clin Psychiatry (2007) 1.54
A randomized, placebo-controlled trial of sertraline for prophylactic treatment of highly recurrent major depressive disorder. Am J Psychiatry (2004) 1.50
Evidence-based guidelines for interpretation of the Hamilton Rating Scale for Depression. J Clin Psychopharmacol (2007) 1.44
Prevention of recurrent episodes of depression with venlafaxine ER in a 1-year maintenance phase from the PREVENT Study. J Clin Psychiatry (2007) 1.40
Predictors of relapse in major depressive disorder. JAMA (1984) 1.19
A review of studies of the Hamilton depression rating scale in healthy controls: implications for the definition of remission in treatment studies of depression. J Nerv Ment Dis (2004) 1.14
Concordance between clinician and patient ratings as predictors of response, remission, and recurrence in major depressive disorder. J Psychiatr Res (2010) 1.03
The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) study: outcomes from the acute and continuation phases. Biol Psychiatry (2007) 0.99
Long term outcome of primary care depression. J Affect Disord (2009) 0.91
Meta-analysis of major depressive disorder relapse and recurrence with second-generation antidepressants. Psychiatr Serv (2008) 0.91
Is the cutoff to define remission on the Hamilton Rating Scale for Depression too high? J Nerv Ment Dis (2005) 0.87
Comparing venlafaxine extended release and fluoxetine for preventing the recurrence of major depression: results from the PREVENT study. J Psychiatr Res (2011) 0.84
Definitions of recovery and outcomes of major depression: results from a 10-year follow-up. Acta Psychiatr Scand (2007) 0.84
Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial. Lancet (2002) 14.14
The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biol Psychiatry (2003) 13.60
The long-term natural history of the weekly symptomatic status of bipolar I disorder. Arch Gen Psychiatry (2002) 6.99
Comparison of scheduled and episodic treatment strategies of infliximab in Crohn's disease. Gastroenterology (2004) 4.26
Report by the ACNP Task Force on response and remission in major depressive disorder. Neuropsychopharmacology (2006) 3.80
A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder. Arch Gen Psychiatry (2003) 3.59
Influence of psychiatric comorbidity on recovery and recurrence in generalized anxiety disorder, social phobia, and panic disorder: a 12-year prospective study. Am J Psychiatry (2005) 3.19
Predictors of spontaneous and systematically assessed suicidal adverse events in the treatment of SSRI-resistant depression in adolescents (TORDIA) study. Am J Psychiatry (2009) 3.17
Are benzodiazepines still the medication of choice for patients with panic disorder with or without agoraphobia? Am J Psychiatry (2003) 3.00
Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn's disease. Gastrointest Endosc (2006) 2.73
Differential responses to psychotherapy versus pharmacotherapy in patients with chronic forms of major depression and childhood trauma. Proc Natl Acad Sci U S A (2003) 2.56
Pharmacokinetically and clinician-determined adherence to an antidepressant regimen and clinical outcome in the TORDIA trial. J Am Acad Child Adolesc Psychiatry (2011) 2.49
Short-term diagnostic stability of schizotypal, borderline, avoidant, and obsessive-compulsive personality disorders. Am J Psychiatry (2002) 2.38
Antidepressants and risks of suicide and suicide attempts: a 27-year observational study. J Clin Psychiatry (2011) 2.35
Psychosocial disability in the course of bipolar I and II disorders: a prospective, comparative, longitudinal study. Arch Gen Psychiatry (2005) 2.32
Impact of publicity concerning pediatric suicidality data on physician practice patterns in the United States. Arch Gen Psychiatry (2007) 2.25
Treatment-resistant depressed youth show a higher response rate if treatment ends during summer school break. J Am Acad Child Adolesc Psychiatry (2011) 2.22
Subthreshold hypomanic symptoms in progression from unipolar major depression to bipolar disorder. Am J Psychiatry (2010) 2.18
Long-term outcome of adolescent depression initially resistant to selective serotonin reuptake inhibitor treatment: a follow-up study of the TORDIA sample. J Clin Psychiatry (2011) 2.10
Substance use disorders among adolescents with bipolar spectrum disorders. Bipolar Disord (2008) 1.94
Chronicity, relapse, and illness--course of panic disorder, social phobia, and generalized anxiety disorder: findings in men and women from 8 years of follow-up. Depress Anxiety (2003) 1.77
The effects of infliximab maintenance therapy on health-related quality of life. Am J Gastroenterol (2003) 1.72
Tachyphylaxis in unipolar major depressive disorder. J Clin Psychiatry (2005) 1.67
Personality disorders and time to remission in generalized anxiety disorder, social phobia, and panic disorder. Arch Gen Psychiatry (2002) 1.66
Does psychosocial functioning improve independent of depressive symptoms? A comparison of nefazodone, psychotherapy, and their combination. Biol Psychiatry (2002) 1.65
Course of subthreshold bipolar disorder in youth: diagnostic progression from bipolar disorder not otherwise specified. J Am Acad Child Adolesc Psychiatry (2011) 1.61
Effects of risperidone augmentation in patients with treatment-resistant depression: Results of open-label treatment followed by double-blind continuation. Neuropsychopharmacology (2006) 1.59
Preliminary findings regarding overweight and obesity in pediatric bipolar disorder. J Clin Psychiatry (2008) 1.56
Double-blind switch study of imipramine or sertraline treatment of antidepressant-resistant chronic depression. Arch Gen Psychiatry (2002) 1.55
The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) Study: Outcomes from the 2-year and combined maintenance phases. J Clin Psychiatry (2007) 1.54
Antiepileptic drugs for bipolar disorder and the risk of suicidal behavior: a 30-year observational study. Am J Psychiatry (2012) 1.51
Therapeutic alliance in depression treatment: controlling for prior change and patient characteristics. J Consult Clin Psychol (2003) 1.50
Nonpsychiatric illness among primary care patients with trauma histories and posttraumatic stress disorder. Psychiatr Serv (2002) 1.50
The comparative clinical phenotype and long term longitudinal episode course of bipolar I and II: a clinical spectrum or distinct disorders? J Affect Disord (2003) 1.48
Longitudinal trajectories and associated baseline predictors in youths with bipolar spectrum disorders. Am J Psychiatry (2014) 1.48
Self-reported depressive symptom measures: sensitivity to detecting change in a randomized, controlled trial of chronically depressed, nonpsychotic outpatients. Neuropsychopharmacology (2005) 1.47
Prevention of recurrent episodes of depression with venlafaxine ER in a 1-year maintenance phase from the PREVENT Study. J Clin Psychiatry (2007) 1.40
Post hoc analysis of the efficacy and safety of desvenlafaxine 50 mg/day in a randomized, placebo-controlled study of perimenopausal and postmenopausal women with major depressive disorder. Menopause (2014) 1.37
Cognitive behavioral analysis system of psychotherapy and brief supportive psychotherapy for augmentation of antidepressant nonresponse in chronic depression: the REVAMP Trial. Arch Gen Psychiatry (2009) 1.35
Psychiatric treatment in primary care patients with anxiety disorders: a comparison of care received from primary care providers and psychiatrists. Am J Psychiatry (2007) 1.34
Does cytokine-induced depression differ from idiopathic major depression in medically healthy individuals? J Affect Disord (2009) 1.28
Phospholipase A2 enzymes, high-dose atorvastatin, and prediction of ischemic events after acute coronary syndromes. Circulation (2012) 1.21
Chronicity in posttraumatic stress disorder and predictors of the course of posttraumatic stress disorder among primary care patients. J Nerv Ment Dis (2004) 1.20
Chronic depression: medication (nefazodone) or psychotherapy (CBASP) is effective when the other is not. Arch Gen Psychiatry (2005) 1.17
Assessing insomnia severity in depression: comparison of depression rating scales and sleep diaries. J Psychiatr Res (2005) 1.16
The role of the subthalamic nucleus in response inhibition: evidence from local field potential recordings in the human subthalamic nucleus. Neuroimage (2011) 1.15
The Child Behavior Checklist (CBCL) and the CBCL-bipolar phenotype are not useful in diagnosing pediatric bipolar disorder. J Child Adolesc Psychopharmacol (2009) 1.15
Group comparisons of DSM-IV subtypes of chronic depression: validity of the distinctions, part 2. J Abnorm Psychol (2003) 1.13
Chronic forms of major depression are still undertreated in the 21st century: systematic assessment of 801 patients presenting for treatment. J Affect Disord (2008) 1.12
Inflammatory biomarkers, death, and recurrent nonfatal coronary events after an acute coronary syndrome in the MIRACL study. J Am Heart Assoc (2013) 1.11
Factor structure and stability of the Anxiety Sensitivity Index in a longitudinal study of anxiety disorder patients. Behav Res Ther (2004) 1.11
Removing ECG noise from surface EMG signals using adaptive filtering. Neurosci Lett (2009) 1.10
Comparing the effects of antidepressants: consensus guidelines for evaluating quantitative reviews of antidepressant efficacy. Neuropsychopharmacology (2005) 1.10
Effective components of TORDIA cognitive-behavioral therapy for adolescent depression: preliminary findings. J Consult Clin Psychol (2009) 1.09
Characteristics and predictors of full and partial recovery from generalized anxiety disorder in primary care patients. J Nerv Ment Dis (2006) 1.09
A 20-year longitudinal observational study of somatic antidepressant treatment effectiveness. Am J Psychiatry (2003) 1.08
Effects of anxiety on the long-term course of depressive disorders. Br J Psychiatry (2011) 1.07
Longitudinal course of bipolar I disorder: duration of mood episodes. Arch Gen Psychiatry (2010) 1.06
Characteristics and course of panic disorder and panic disorder with agoraphobia in primary care patients. Prim Care Companion J Clin Psychiatry (2007) 1.05
Cytochrome P450 2D6 phenotype predicts antidepressant efficacy of venlafaxine: a secondary analysis of 4 studies in major depressive disorder. J Clin Psychiatry (2010) 1.05
Predictors of treatment utilization among women with anorexia and bulimia nervosa. Am J Psychiatry (2002) 1.05
The Trox-2 Hox/ParaHox gene of Trichoplax (Placozoa) marks an epithelial boundary. Dev Genes Evol (2004) 1.04
Psychosocial impairment and recurrence of major depression. Compr Psychiatry (2004) 1.04
A role for the subthalamic nucleus in response inhibition during conflict. J Neurosci (2012) 1.04
Relationships among psychosocial functioning, diagnostic comorbidity, and the recurrence of generalized anxiety disorder, panic disorder, and major depression. J Anxiety Disord (2004) 1.03
The distinct temperament profiles of bipolar I, bipolar II and unipolar patients. J Affect Disord (2006) 1.02
Differential effects of nefazodone and cognitive behavioral analysis system of psychotherapy on insomnia associated with chronic forms of major depression. J Clin Psychiatry (2002) 1.01
Retracted Plasma PCSK9 levels and clinical outcomes in the TNT (Treating to New Targets) trial: a nested case-control study. J Am Coll Cardiol (2012) 1.01
Significance of cigarette smoking among youths with bipolar disorder. Am J Addict (2008) 1.00
A randomized, placebo-controlled trial of risperidone augmentation for patients with difficult-to-treat unipolar, non-psychotic major depression. J Psychiatr Res (2008) 1.00
An integrated analysis of the efficacy of desvenlafaxine compared with placebo in patients with major depressive disorder. CNS Spectr (2009) 1.00
Frequency and patterns of psychiatric comorbidity in a sample of primary care patients with anxiety disorders. Compr Psychiatry (2004) 0.99
The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) study: outcomes from the acute and continuation phases. Biol Psychiatry (2007) 0.99
Retracted Prediction of cardiovascular events in statin-treated stable coronary patients by lipid and nonlipid biomarkers. J Am Coll Cardiol (2011) 0.99
Response to infliximab treatment in Crohn's disease is not associated with mutations in the CARD15 (NOD2) gene: an analysis in 534 patients from two multicenter, prospective GCP-level trials. Pharmacogenetics (2002) 0.98
Distinguishing bipolar major depression from unipolar major depression with the screening assessment of depression-polarity (SAD-P). J Clin Psychiatry (2006) 0.97
Antidepressant exposure as a predictor of clinical outcomes in the Treatment of Resistant Depression in Adolescents (TORDIA) study. J Clin Psychopharmacol (2011) 0.96
Longitudinal course of obsessive-compulsive disorder in patients with anxiety disorders: a 15-year prospective follow-up study. Compr Psychiatry (2011) 0.95
Cognitive-behavioral analysis system of psychotherapy as a maintenance treatment for chronic depression. J Consult Clin Psychol (2004) 0.94
Predicting recovery from episodes of major depression. J Affect Disord (2007) 0.94
Is anyone really M.A.D.?: the occurrence and course of mixed anxiety-depressive disorder in a sample of primary care patients. J Nerv Ment Dis (2005) 0.94
Comorbid anxiety in children and adolescents with bipolar spectrum disorders: prevalence and clinical correlates. J Clin Psychiatry (2010) 0.94
Use of benzodiazepines and selective serotonin reuptake inhibitors in middle-aged and older adults with anxiety disorders: a longitudinal and prospective study. Am J Geriatr Psychiatry (2008) 0.93
Preventing recurrent depression: long-term treatment for major depressive disorder. J Clin Psychiatry (2007) 0.93
Health-related Quality of Life across the anxiety disorders: findings from a sample of primary care patients. J Anxiety Disord (2010) 0.93
Placebo-controlled continuation treatment with mirtazapine: acute pattern of response predicts relapse. Neuropsychopharmacology (2004) 0.93
Occupational impairment and Social Anxiety Disorder in a sample of primary care patients. J Affect Disord (2010) 0.93
The naturalistic course of unipolar major depression in the absence of somatic therapy. J Nerv Ment Dis (2006) 0.93
Incremental cost-effectiveness of combined therapy vs medication only for youth with selective serotonin reuptake inhibitor-resistant depression: treatment of SSRI-resistant depression in adolescents trial findings. Arch Gen Psychiatry (2011) 0.93
Impact of physical and sexual abuse on treatment response in the Treatment of Resistant Depression in Adolescent Study (TORDIA). J Am Acad Child Adolesc Psychiatry (2011) 0.93
Unipolar mania over the course of a 20-year follow-up study. Am J Psychiatry (2003) 0.92
The history and current state of antidepressant clinical trial design: a call to action for proof-of-concept studies. J Clin Psychiatry (2008) 0.92